Concepts (290)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 19 | 2019 | 341 | 3.090 |
Why?
|
| Mammography | 12 | 2017 | 42 | 2.260 |
Why?
|
| Racism | 4 | 2022 | 33 | 1.900 |
Why?
|
| Kidney Failure, Chronic | 15 | 2021 | 140 | 1.870 |
Why?
|
| Early Detection of Cancer | 5 | 2018 | 72 | 1.850 |
Why?
|
| Healthcare Disparities | 7 | 2023 | 79 | 1.770 |
Why?
|
| Health Services Accessibility | 14 | 2021 | 94 | 1.750 |
Why?
|
| Health Status Disparities | 5 | 2020 | 67 | 1.610 |
Why?
|
| Renal Replacement Therapy | 9 | 2011 | 22 | 1.510 |
Why?
|
| Registries | 14 | 2011 | 161 | 1.500 |
Why?
|
| Kidney Transplantation | 6 | 2021 | 112 | 1.370 |
Why?
|
| Medically Uninsured | 2 | 2021 | 11 | 1.260 |
Why?
|
| Physicians | 2 | 2022 | 103 | 1.150 |
Why?
|
| Humans | 73 | 2023 | 25178 | 1.020 |
Why?
|
| Primary Health Care | 3 | 2021 | 87 | 0.920 |
Why?
|
| Practice Patterns, Physicians' | 5 | 2018 | 100 | 0.920 |
Why?
|
| Health Facilities | 1 | 2023 | 18 | 0.840 |
Why?
|
| Chicago | 23 | 2019 | 782 | 0.840 |
Why?
|
| Middle Aged | 40 | 2021 | 8135 | 0.840 |
Why?
|
| Female | 53 | 2021 | 13844 | 0.830 |
Why?
|
| Health Equity | 1 | 2023 | 18 | 0.830 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 118 | 0.830 |
Why?
|
| Human Rights | 1 | 2022 | 3 | 0.800 |
Why?
|
| Referral and Consultation | 3 | 2021 | 74 | 0.780 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 142 | 0.770 |
Why?
|
| Ambulatory Care Facilities | 1 | 2021 | 34 | 0.750 |
Why?
|
| Adult | 36 | 2021 | 7087 | 0.750 |
Why?
|
| Community Health Services | 1 | 2021 | 29 | 0.750 |
Why?
|
| Health Personnel | 1 | 2022 | 96 | 0.740 |
Why?
|
| Dyslipidemias | 2 | 2018 | 15 | 0.740 |
Why?
|
| Socioeconomic Factors | 11 | 2020 | 276 | 0.730 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 42 | 0.710 |
Why?
|
| Emergency Service, Hospital | 4 | 2022 | 222 | 0.690 |
Why?
|
| Mass Screening | 10 | 2017 | 161 | 0.680 |
Why?
|
| Hospitalization | 2 | 2022 | 282 | 0.680 |
Why?
|
| Cancer Care Facilities | 1 | 2019 | 6 | 0.660 |
Why?
|
| Carcinoma, Ductal | 1 | 2019 | 5 | 0.660 |
Why?
|
| Cholesterol, LDL | 2 | 2018 | 24 | 0.630 |
Why?
|
| Cardiovascular Diseases | 3 | 2018 | 327 | 0.630 |
Why?
|
| Renal Dialysis | 8 | 2021 | 105 | 0.630 |
Why?
|
| Violence | 1 | 2018 | 28 | 0.610 |
Why?
|
| Practice Guidelines as Topic | 7 | 2018 | 277 | 0.610 |
Why?
|
| Social Determinants of Health | 1 | 2018 | 30 | 0.610 |
Why?
|
| Aged | 29 | 2021 | 8397 | 0.600 |
Why?
|
| Survival Rate | 6 | 2010 | 310 | 0.580 |
Why?
|
| Mortality | 5 | 2018 | 81 | 0.560 |
Why?
|
| Multicenter Studies as Topic | 3 | 2010 | 53 | 0.520 |
Why?
|
| Residence Characteristics | 5 | 2019 | 203 | 0.510 |
Why?
|
| Undocumented Immigrants | 1 | 2015 | 2 | 0.500 |
Why?
|
| Health Policy | 2 | 2015 | 50 | 0.500 |
Why?
|
| Value of Life | 1 | 2015 | 1 | 0.500 |
Why?
|
| Insurance Coverage | 1 | 2015 | 12 | 0.490 |
Why?
|
| Pregnancy Outcome | 3 | 2014 | 16 | 0.490 |
Why?
|
| Young Adult | 13 | 2021 | 1749 | 0.470 |
Why?
|
| United Kingdom | 10 | 2011 | 46 | 0.470 |
Why?
|
| Male | 29 | 2021 | 13545 | 0.450 |
Why?
|
| Hospitals | 4 | 2022 | 145 | 0.440 |
Why?
|
| United States | 10 | 2021 | 1899 | 0.430 |
Why?
|
| Waiting Lists | 2 | 2010 | 14 | 0.420 |
Why?
|
| Outpatient Clinics, Hospital | 4 | 2002 | 11 | 0.420 |
Why?
|
| Cause of Death | 3 | 2010 | 55 | 0.410 |
Why?
|
| Community Health Planning | 2 | 2009 | 20 | 0.410 |
Why?
|
| Tissue Donors | 2 | 2010 | 68 | 0.400 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 584 | 0.400 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 832 | 0.390 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2019 | 754 | 0.390 |
Why?
|
| Retrospective Studies | 10 | 2021 | 3105 | 0.380 |
Why?
|
| Adolescent | 9 | 2021 | 1998 | 0.370 |
Why?
|
| Peritoneal Dialysis | 1 | 2011 | 22 | 0.370 |
Why?
|
| National Health Programs | 2 | 2010 | 3 | 0.360 |
Why?
|
| Cesarean Section | 4 | 2014 | 28 | 0.360 |
Why?
|
| Renal Insufficiency | 1 | 2010 | 13 | 0.350 |
Why?
|
| Hemoglobins | 3 | 2009 | 75 | 0.350 |
Why?
|
| Risk Assessment | 7 | 2018 | 592 | 0.340 |
Why?
|
| Community Participation | 1 | 2009 | 16 | 0.330 |
Why?
|
| Aged, 80 and over | 12 | 2018 | 4503 | 0.320 |
Why?
|
| Risk Factors | 9 | 2018 | 2166 | 0.320 |
Why?
|
| ErbB Receptors | 1 | 2009 | 50 | 0.320 |
Why?
|
| Breech Presentation | 1 | 2008 | 3 | 0.320 |
Why?
|
| Version, Fetal | 1 | 2008 | 3 | 0.320 |
Why?
|
| Medical Audit | 1 | 2008 | 6 | 0.320 |
Why?
|
| Incidence | 8 | 2019 | 664 | 0.310 |
Why?
|
| Pregnancy | 8 | 2020 | 302 | 0.310 |
Why?
|
| Smoking | 2 | 2005 | 165 | 0.290 |
Why?
|
| Hospitals, Public | 6 | 2002 | 25 | 0.290 |
Why?
|
| Annual Reports as Topic | 3 | 2010 | 3 | 0.270 |
Why?
|
| Guideline Adherence | 3 | 2018 | 53 | 0.260 |
Why?
|
| Intubation | 1 | 2005 | 6 | 0.260 |
Why?
|
| Heroin Dependence | 1 | 2005 | 9 | 0.260 |
Why?
|
| Public Health | 2 | 2017 | 62 | 0.260 |
Why?
|
| Cocaine-Related Disorders | 1 | 2005 | 11 | 0.260 |
Why?
|
| Extraction, Obstetrical | 2 | 1995 | 2 | 0.260 |
Why?
|
| Tobacco Use Disorder | 1 | 2005 | 17 | 0.250 |
Why?
|
| Smoking Cessation | 1 | 2005 | 46 | 0.240 |
Why?
|
| Geographic Information Systems | 1 | 2004 | 3 | 0.240 |
Why?
|
| Treatment Outcome | 5 | 2018 | 3146 | 0.240 |
Why?
|
| Diabetes, Gestational | 2 | 2014 | 8 | 0.230 |
Why?
|
| Time Factors | 6 | 2018 | 1327 | 0.230 |
Why?
|
| Asthma | 1 | 2005 | 104 | 0.230 |
Why?
|
| Age Factors | 6 | 2018 | 720 | 0.230 |
Why?
|
| New Zealand | 6 | 2019 | 11 | 0.220 |
Why?
|
| Health Status Indicators | 1 | 2004 | 73 | 0.220 |
Why?
|
| Cities | 3 | 2018 | 12 | 0.220 |
Why?
|
| Poverty | 5 | 2010 | 86 | 0.220 |
Why?
|
| Diabetes Mellitus | 2 | 2002 | 121 | 0.220 |
Why?
|
| Commerce | 1 | 2023 | 11 | 0.210 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 1994 | 30 | 0.210 |
Why?
|
| Patient Transfer | 2 | 1996 | 18 | 0.210 |
Why?
|
| Uncompensated Care | 1 | 2002 | 1 | 0.200 |
Why?
|
| Databases, Factual | 3 | 2019 | 306 | 0.200 |
Why?
|
| Delivery, Obstetric | 2 | 2019 | 12 | 0.200 |
Why?
|
| Morbidity | 2 | 2001 | 56 | 0.200 |
Why?
|
| Health Priorities | 1 | 2001 | 4 | 0.200 |
Why?
|
| Public Health Administration | 1 | 2001 | 9 | 0.190 |
Why?
|
| Patient Compliance | 3 | 2018 | 138 | 0.190 |
Why?
|
| Social Class | 3 | 2010 | 61 | 0.190 |
Why?
|
| Aftercare | 1 | 2021 | 23 | 0.190 |
Why?
|
| Research Design | 2 | 2020 | 174 | 0.180 |
Why?
|
| Health Surveys | 3 | 2007 | 82 | 0.180 |
Why?
|
| Dystocia | 1 | 2020 | 1 | 0.180 |
Why?
|
| Income | 2 | 2005 | 70 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2011 | 67 | 0.170 |
Why?
|
| Sociology, Medical | 1 | 2019 | 3 | 0.170 |
Why?
|
| Hospitals, Urban | 2 | 1998 | 34 | 0.160 |
Why?
|
| Survival Analysis | 2 | 2009 | 233 | 0.160 |
Why?
|
| Illinois | 4 | 2015 | 222 | 0.160 |
Why?
|
| Mortality, Premature | 1 | 2018 | 6 | 0.160 |
Why?
|
| Infant, Low Birth Weight | 1 | 2018 | 14 | 0.160 |
Why?
|
| Quality of Health Care | 4 | 2020 | 116 | 0.160 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 15 | 0.150 |
Why?
|
| Global Health | 1 | 2018 | 39 | 0.150 |
Why?
|
| Infant, Newborn | 5 | 2019 | 522 | 0.150 |
Why?
|
| General Practice | 1 | 2018 | 2 | 0.150 |
Why?
|
| England | 4 | 2011 | 13 | 0.150 |
Why?
|
| Germany | 1 | 2017 | 6 | 0.150 |
Why?
|
| Biomarkers | 2 | 2018 | 537 | 0.150 |
Why?
|
| Prevalence | 5 | 2014 | 421 | 0.150 |
Why?
|
| Cholesterol | 1 | 2018 | 43 | 0.150 |
Why?
|
| Women's Health | 2 | 2017 | 171 | 0.150 |
Why?
|
| Medical Overuse | 1 | 2017 | 7 | 0.150 |
Why?
|
| Down-Regulation | 1 | 2017 | 90 | 0.150 |
Why?
|
| Health Education | 3 | 1994 | 39 | 0.140 |
Why?
|
| False Negative Reactions | 1 | 2016 | 13 | 0.140 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 294 | 0.140 |
Why?
|
| Quality Control | 1 | 2016 | 26 | 0.140 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 174 | 0.140 |
Why?
|
| Facility Regulation and Control | 1 | 1996 | 1 | 0.140 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 467 | 0.140 |
Why?
|
| Observer Variation | 1 | 2016 | 87 | 0.140 |
Why?
|
| Urban Health | 3 | 2004 | 21 | 0.140 |
Why?
|
| Epidemiologic Methods | 2 | 2015 | 16 | 0.140 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 36 | 0.130 |
Why?
|
| Urban Population | 5 | 2005 | 131 | 0.130 |
Why?
|
| Emergency Medical Services | 1 | 1996 | 29 | 0.130 |
Why?
|
| Comorbidity | 1 | 2017 | 450 | 0.130 |
Why?
|
| Wales | 3 | 2010 | 4 | 0.130 |
Why?
|
| Civil Defense | 1 | 2015 | 5 | 0.130 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 33 | 0.130 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 6 | 0.130 |
Why?
|
| Financing, Government | 1 | 2015 | 10 | 0.130 |
Why?
|
| Patient Safety | 1 | 2016 | 48 | 0.120 |
Why?
|
| Reimbursement Mechanisms | 1 | 2015 | 11 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 1998 | 264 | 0.120 |
Why?
|
| Hospitals, Maternity | 1 | 1995 | 3 | 0.120 |
Why?
|
| Stereotyping | 1 | 2015 | 8 | 0.120 |
Why?
|
| Schools, Medical | 1 | 2015 | 19 | 0.120 |
Why?
|
| Birth Weight | 1 | 2014 | 35 | 0.120 |
Why?
|
| Prognosis | 3 | 2012 | 726 | 0.120 |
Why?
|
| Faculty, Medical | 1 | 2015 | 36 | 0.120 |
Why?
|
| Neoplasms | 1 | 2017 | 213 | 0.120 |
Why?
|
| Students, Medical | 1 | 2015 | 42 | 0.120 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 642 | 0.120 |
Why?
|
| Syphilis | 1 | 1994 | 1 | 0.120 |
Why?
|
| HIV Seroprevalence | 1 | 1994 | 3 | 0.120 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1994 | 10 | 0.110 |
Why?
|
| Community Health Nursing | 1 | 1994 | 8 | 0.110 |
Why?
|
| Postpartum Period | 1 | 1993 | 20 | 0.110 |
Why?
|
| Cohort Studies | 5 | 2019 | 1756 | 0.110 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 78 | 0.100 |
Why?
|
| Hemodialysis, Home | 1 | 2011 | 1 | 0.090 |
Why?
|
| Tetanus | 1 | 2011 | 1 | 0.090 |
Why?
|
| Disasters | 1 | 2011 | 2 | 0.090 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2011 | 13 | 0.090 |
Why?
|
| Developing Countries | 1 | 2011 | 12 | 0.090 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2010 | 18 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2010 | 76 | 0.090 |
Why?
|
| Patient Selection | 2 | 2011 | 188 | 0.090 |
Why?
|
| Prospective Studies | 4 | 2009 | 1589 | 0.080 |
Why?
|
| Hemodialysis Units, Hospital | 1 | 2009 | 1 | 0.080 |
Why?
|
| Living Donors | 1 | 2009 | 6 | 0.080 |
Why?
|
| Advisory Committees | 1 | 2009 | 22 | 0.080 |
Why?
|
| Health Services Research | 3 | 2002 | 39 | 0.080 |
Why?
|
| HIV Infections | 1 | 1994 | 432 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2009 | 243 | 0.080 |
Why?
|
| Counseling | 1 | 2008 | 40 | 0.080 |
Why?
|
| Logistic Models | 1 | 2009 | 343 | 0.080 |
Why?
|
| Europe | 3 | 2010 | 66 | 0.080 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 1621 | 0.080 |
Why?
|
| Interviews as Topic | 2 | 2002 | 113 | 0.080 |
Why?
|
| Mexico | 1 | 2007 | 17 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 438 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2007 | 61 | 0.070 |
Why?
|
| Unemployment | 1 | 2005 | 2 | 0.060 |
Why?
|
| Reoperation | 1 | 2009 | 807 | 0.060 |
Why?
|
| Infant | 2 | 2009 | 483 | 0.060 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2004 | 2 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2009 | 588 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 13 | 0.060 |
Why?
|
| Acute Disease | 1 | 2005 | 185 | 0.060 |
Why?
|
| Chest Pain | 1 | 2004 | 18 | 0.060 |
Why?
|
| Glucose Tolerance Test | 2 | 2014 | 12 | 0.060 |
Why?
|
| Attitude to Health | 3 | 2011 | 88 | 0.060 |
Why?
|
| Educational Status | 1 | 2005 | 279 | 0.060 |
Why?
|
| Lung | 1 | 2004 | 153 | 0.060 |
Why?
|
| Disease Outbreaks | 2 | 2011 | 76 | 0.060 |
Why?
|
| Critical Care | 1 | 2005 | 190 | 0.050 |
Why?
|
| Intensive Care Units | 1 | 2005 | 277 | 0.050 |
Why?
|
| Disease Progression | 1 | 2005 | 649 | 0.050 |
Why?
|
| Child | 2 | 2009 | 1232 | 0.050 |
Why?
|
| Policy | 1 | 2021 | 10 | 0.050 |
Why?
|
| Poverty Areas | 1 | 2001 | 9 | 0.050 |
Why?
|
| Aging | 1 | 2010 | 1520 | 0.050 |
Why?
|
| Health Care Surveys | 2 | 1998 | 57 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2009 | 250 | 0.050 |
Why?
|
| Medicare | 1 | 2021 | 107 | 0.050 |
Why?
|
| Parathyroid Hormone | 2 | 2010 | 22 | 0.040 |
Why?
|
| Axilla | 1 | 2019 | 11 | 0.040 |
Why?
|
| Traction | 1 | 2019 | 29 | 0.040 |
Why?
|
| Life Expectancy | 1 | 2018 | 19 | 0.040 |
Why?
|
| Ontario | 1 | 2018 | 15 | 0.040 |
Why?
|
| North America | 1 | 2018 | 35 | 0.040 |
Why?
|
| Medical Indigency | 1 | 1998 | 1 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 66 | 0.040 |
Why?
|
| Italy | 1 | 2018 | 13 | 0.040 |
Why?
|
| Hospital Charges | 1 | 1998 | 13 | 0.040 |
Why?
|
| Geography | 1 | 2018 | 16 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2018 | 93 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2018 | 539 | 0.030 |
Why?
|
| Community Health Centers | 3 | 1993 | 11 | 0.030 |
Why?
|
| Pacific Islands | 1 | 1995 | 2 | 0.030 |
Why?
|
| Analgesia, Obstetrical | 1 | 1995 | 26 | 0.030 |
Why?
|
| Analgesia, Epidural | 1 | 1995 | 51 | 0.030 |
Why?
|
| Organizational Policy | 1 | 1995 | 15 | 0.030 |
Why?
|
| Fetal Macrosomia | 1 | 2014 | 1 | 0.030 |
Why?
|
| Labor, Induced | 1 | 2014 | 3 | 0.030 |
Why?
|
| Fasting | 1 | 2014 | 13 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 42 | 0.030 |
Why?
|
| Health Resources | 1 | 2014 | 20 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 1994 | 18 | 0.030 |
Why?
|
| Fetal Death | 1 | 1993 | 5 | 0.030 |
Why?
|
| Demography | 2 | 2011 | 69 | 0.030 |
Why?
|
| Medical Records | 1 | 1993 | 29 | 0.030 |
Why?
|
| Program Evaluation | 1 | 1994 | 117 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 1994 | 156 | 0.020 |
Why?
|
| New York City | 1 | 2011 | 14 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2011 | 38 | 0.020 |
Why?
|
| Clostridium tetani | 1 | 2011 | 1 | 0.020 |
Why?
|
| Tetanus Toxoid | 1 | 2011 | 1 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2011 | 10 | 0.020 |
Why?
|
| Endemic Diseases | 1 | 2011 | 7 | 0.020 |
Why?
|
| Metronidazole | 1 | 2011 | 5 | 0.020 |
Why?
|
| Wounds, Penetrating | 1 | 2011 | 7 | 0.020 |
Why?
|
| Vaccination | 1 | 2011 | 29 | 0.020 |
Why?
|
| Phosphates | 1 | 2010 | 19 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 35 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2009 | 22 | 0.020 |
Why?
|
| Asia | 1 | 2009 | 9 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 315 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 195 | 0.020 |
Why?
|
| Papanicolaou Test | 3 | 1993 | 8 | 0.020 |
Why?
|
| Vaginal Smears | 3 | 1993 | 11 | 0.020 |
Why?
|
| Ethics, Institutional | 1 | 1987 | 1 | 0.020 |
Why?
|
| Insurance, Hospitalization | 1 | 1987 | 2 | 0.020 |
Why?
|
| Government Regulation | 1 | 1987 | 3 | 0.020 |
Why?
|
| Federal Government | 1 | 1987 | 3 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 1987 | 23 | 0.020 |
Why?
|
| Calcium | 1 | 2010 | 472 | 0.020 |
Why?
|
| Transfer Agreement | 1 | 1986 | 1 | 0.020 |
Why?
|
| Patient Admission | 1 | 1986 | 24 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2004 | 12 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2004 | 22 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2005 | 129 | 0.020 |
Why?
|
| Physical Examination | 2 | 1993 | 101 | 0.010 |
Why?
|
| Health Services | 1 | 1998 | 8 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1998 | 239 | 0.010 |
Why?
|
| Computers | 1 | 1976 | 22 | 0.010 |
Why?
|
| Appointments and Schedules | 1 | 1993 | 13 | 0.010 |
Why?
|
| Data Collection | 1 | 1993 | 89 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1986 | 7 | 0.000 |
Why?
|
| Time | 1 | 1986 | 13 | 0.000 |
Why?
|